U.S. Flow Cytometry Market - Databook 2025 to 2034

The U.S. flow cytometry market size was estimated at USD 2,025 million in 2024 and is projected to be worth around USD 4,267 million by 2034, growing at a CAGR of 7.73% from 2025 to 2034.

Highlights of the U.S. Flow Cytometry Market

• By product, the instruments segment underwent notable growth in the U.S. flow cytometry market during 2024.
• By product, the reagents & consumables segment will gain a significant share of the market over the studied period of 2025 to 2034.
• By technology, the cell-based segment enjoyed a prominent position in the U.S. flow cytometry market during 2024.
• By technology, the bead-based segment is predicted to witness significant growth in the market over the forecast period.
• By application, the research segment captured a significant portion of the U.S. flow cytometry market in 2024.
• By application, the clinical segment is projected to expand rapidly in the market in the coming years.
• By end-use, the universities segment maintained a leading position in the U.S. flow cytometry market in 2024.
• By end-use, the research institutions segment is anticipated to grow with the highest CAGR in the market during the studied years.

Industry Valuation and Growth Rate Projection

Flow cytometry is a technology that provides rapid multi-parametric analysis of single cells in solution. Flow cytometers use lasers as light sources to produce both fluorescent and scattered light signals that are read by detectors like photomultiplier tubes and photodiodes. It is a laser-based lab test that can detect chemical and physical differences of cells or particles. The U.S. flow cytometry market growth is driven by increasing awareness about the benefits of flow cytometry in research and diagnostics, growing demand for user-friendly and automated flow cytometry systems in clinical laboratories, and increasing investment in research and development.

The U.S. flow cytometry market research applications include intracellular calcium flex, cell proliferation assays, apoptosis, cell cycle analysis, and cell sorting. Flow cytometry can be used to quantify the number and proportion of specific cell types in a heterogenous mixture, by examining the expression of proteins expressed on the surface of cells. It is used to evaluate bone marrow, peripheral blood, and other fluids in our body.

What are the Trends in the U.S. Flow Cytometry Market?

• The trends in the U.S. flow cytometry market include increasing awareness about the benefits of flow cytometry in research and diagnostics, growing demand for user-friendly and automated flow cytometry systems in clinical laboratories, and increasing investment in research and development.
• Increasing awareness about the flow cytometry in research and diagnostics: Flow cytometry can help to diagnose many conditions, including cancer and infectious diseases. In research, flow cytometry studies are used to identify and quantify immune cells and characterize hematological malignancies. They can measure cell granularity and cell size. Flow cytometry is a diagnostic tool that may help doctors diagnose, stage, and follow the treatment progress of a cancer patient.
• Growing demand for user-friendly and automated flow cytometry systems in clinical laboratories: A user-friendly and automated flow cytometry system is an open-source software tool for automatically converting flow cytometry data from arbitrary to calibrated units. Automation flow cytometry assays through flexible solutions for high-throughput screening using the automated liquid handling workstation.
• Increasing investment in research and development: Increasing investment in research and development benefits include trend matching, advancements in marketing abilities, cost management benefits, and increased market participation are all reasons companies invest in R&D. It can help a company to stay ahead and follow market trends and keep the company relevant.

What are the Restraints in the U.S. Flow Cytometry Market?

• The restraints in the U.S. flow cytometry market include a lack of standardized protocols for instruments and a need for skilled professionals.
• Lack of standardized protocol for instruments: Protocol standardization plays an important role in ensuring that different devices and systems can work together seamlessly. Lack of standardized protocols within organizations can lead to decreased morale, confusion, and misunderstanding.
• Need for skilled professionals: There is a need for skilled professionals due to talent attraction & retention, employee empowerment, global competitiveness, continuous improvement, cross functional collaboration, risk management, regulatory compliance, improved customer satisfaction, positive impact on company reputation, better decision making, cost savings in long run, faster adaptation to change, and higher quality of work.

Opportunity

• Technological innovations in clinical applications: Technological innovations in clinical applications transformed healthcare and led to faster and more accurate diagnoses.
• Technological innovations' benefits include better medical device management, reduced errors, streamlined workflow, lower healthcare costs, increased patient education, improved treatment & diagnosis, and public health improvement.

Recent Developments in the U.S. Flow Cytometry Market

• In May 2025, the ‘Flow Cytometry’ test, a specialized diagnostic tool used to identify different types of blood cancer, was launched by the BP Koirala Memorial Cancer Hospital in Chitwan. BP Koirala Cancer Hospital launches ‘Flow Cytometry’ test « Khabarhub
• In May 2025, the launch of the Cytek Aurora Evo System, a new full-spectrum flow cytometer that improves on its flagship Cytek Aurora system, was launched by Cytek Biosciences, Inc.